Seladelpar (CymaBay) may replace obeticholic acid as a second line therapy for PBC. About 40% of patient with PBC may not respond to Ursodeoxycholic acid (UDCA) which is the current first line therapy. Similarly, half of patient's fail to respond to obeticholic acid.
top of page
Gastroenterology and Hepatology
Alexandra Modiri MD
Kian Makipour MD MS
Houshang Makipour MD AGAF
2280 Opitz Blvd, Suite 200
Woodbridge, VA 22191
703-580-7433
Online Healow Appointment Requests Must First be Confirmed by the Office!
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday
8:30am – 4;30pm
7:30am – 3:30pm
8:30am – 4:30pm
7:30am – 3:30pm
8:30am – 4:30pm
CLOSED
CLOSED
bottom of page
Comments